Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sudeep PharmaBOM:544619 -1.10%18 PB Ratio is 11.11 as of Aug. 04, 2026, which is 15% above its 10-year median of 9.66. GuruFocus rates BOM:544619 with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 922 Drug Manufacturers companies, Sudeep Pharma ranks worse than 93.93% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-04), Sudeep Pharma's share price is ₹868.55. Sudeep Pharma's Book Value per Share for the quarter that ended in Mar. 2026 was ₹78.21. Hence, Sudeep Pharma's PB Ratio of today is 11.11.
Warning Sign:
Sudeep Pharma Ltd stock PB Ratio (=10.57) is close to 1-year high of 11.63.
The historical rank and industry rank for Sudeep Pharma's PB Ratio or its related term are showing as below:
BOM:544619'
s PB Ratio Range Over the Past 10 Years
Min: 7.8 Med: 9.66 Max: 11.63
Current: 11.51
During the past 4 years, Sudeep Pharma's highest PB Ratio was 11.63. The lowest was 7.80. And the median was 9.66.
BOM:544619's PB Ratio is ranked worse than 93.93% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.89
vs BOM:544619: 11.51
During the past 12 months, Sudeep Pharma's average Book Value Per Share Growth Rate was 80.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 58.20% per year.
During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Sudeep Pharma was 58.20% per year. The lowest was 58.20% per year. And the median was 58.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sudeep Pharma PB Ratio Related Terms
Sudeep Pharma PB Ratio Historical Data
* Premium members only.
The historical data trend for Sudeep Pharma's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sudeep Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sudeep Pharma PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sudeep Pharma's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sudeep Pharma's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Sudeep Pharma's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sudeep Pharma (BOM:544619) has a PB Ratio of 11.11 as of Aug. 04, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sudeep Pharma and its competitors. This is 15% above median its historical median of 9.66. Over the past decade, Sudeep Pharma's PB Ratio has ranged from 7.80 to 11.63. According to the industry distribution chart, Sudeep Pharma ranks #866 out of 922 companies in the Drug Manufacturers industry, placing it in the top 93.9%.
Is Sudeep Pharma's PB Ratio too high?
Sudeep Pharma's current PB Ratio of 11.11 is 15% above median its 10-year median of 9.66. Over the past 10 years, this metric has ranged from a low of 7.80 to a high of 11.63. The Drug Manufacturers industry median PB Ratio is 1.89. Sudeep Pharma's value of 11.11 is 487.8% above this industry median. Based on the distribution chart, Sudeep Pharma ranks #866 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sudeep Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sudeep Pharma's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sudeep Pharma ranks #866 out of 922 companies for PB Ratio. This places Sudeep Pharma in the lower half of its industry. The industry median PB Ratio is 1.89. Sudeep Pharma's value of 11.11 is 487.8% above this benchmark. Historically, Sudeep Pharma's own PB Ratio has ranged from 7.80 to 11.63 over the past decade. While the company's 10-year median is 9.66 vs. the industry median of 1.89, Sudeep Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.89, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sudeep Pharma's current PB Ratio of 11.11 is 487.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sudeep Pharma and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sudeep Pharma's current PB Ratio is 11.11, which is 15% above median its own 10-year median of 9.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudeep Pharma stock overvalued right now?
Sudeep Pharma (BOM:544619) has a current PB Ratio of 11.11. The current PB Ratio is 11.11, which is 15% above median its 10-year median of 9.66 and 487.8% above the Drug Manufacturers industry median of 1.89. Sudeep Pharma's overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sudeep Pharma (BOM:544619), the current PB Ratio is 11.11 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sudeep Pharma Ltd is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries and is dedicated to contributing to the healthcare ecosystem. The company operates in two business verticals: Pharmaceutical, food, and nutrition. It focuses on providing refined, mineral-based single ingredients essential to the pharmaceutical, food, and nutrition industries and Specialty ingredients: It pertains manufacturing of specialty ingredients using advance technology solutions. The maximum revenue is generated from the Pharmaceutical, food, and nutrition segment. Geographically, it has presence in the United States, South America, Europe, the Middle East, Africa, and Asia-Pacific.
18GF Score
Get the complete analysis for BOM:544619
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544619 has been successfully added to your 
